BSEInsider Trading / SAST28 Sept 2026 · 28 Sept 2026, 12:41 pm

Intimation of Closure of Trading Window

Kwality Pharmaceuticals Ltd · 539997

✦ AI Summary

Kwality Pharmaceuticals Ltd has announced the closure of its trading window for all designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half-year ended September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern5/10
Regulatory Risk5/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Kwality Pharmaceuticals Ltd - 539997 - Closure of Trading Window

Attachments (1)

📄

f2d83aae-6b74-4fa0-8d8b-2a95cb4ad9d1.pdf

pdf

Download →
View document text
Date: September 28, 2026 The Department of Corporate Services, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400001. BSE Scrip Code: 539997 SUBJECT: INTIMATION OF CLOSURE OF TRADING WINDOW Dear Sir/ Madam, Pursuant to SEBI( Prohibition of Insider Trading) Regulations, 2015 as amended from time to time read with Company’s Code of Conduct for Prevention of Insider Trading in securities, the trading window for dealing in Equity Shares of the Company for all Designated Persons and their Immediate Relatives covered under Company’s Code of Conduct for prevention of Insider Trading in Securities shall remain closed from Thursday, October 1, 2026 till 48 hours after the declaration of Unaudited Financial Results of the Company for the Quarter and Half year ended September 30, 2026. Accordingly, all Designated Persons and their Immediate Relatives have been advised not to deal in the Equity Shares of the Company during the aforesaid period of closure of the Trading Window. The date of Board Meeting of the Company for consideration and declaration of the of the Unaudited Financial Results for the Quarter and Half year ended September 30, 2026 shall be intimated separately in due course. Kindly take the above information on record. Thanking you. Yours faithfully, For KWALITY PHARMACEUTICALS LIMITED RAMESH KUMAR Managing Director DIN: 00462656